No Detail Found!

Effect of Mesalazine Combined with Bifid Triple Viable on Ulcerative Colitis

Author(s)
Qi Zhao Department of Medical Technology and Engineering, Zhengzhou Railway Vocational and Technical College,Zhengzhou, 451460,China
Yuanyuan Hou Department of Medical Technology and Engineering, Zhengzhou Railway Vocational and Technical College,Zhengzhou, 451460,China
Xiangdong Jin Department of Medical Technology and Engineering, Zhengzhou Railway Vocational and Technical College,Zhengzhou, 451460,China
Chen Zhang Preventive Dentistry,The First Afiliated Hospital of Zhengzhou University,Zhengzhou, 450002,China
Abstract
Objective of this study was to observe the clinical effect of mesalazine combined with bifid triple viable (BTV) on ulcerative colitis. One hundred sixty patients with ulcerative colitis were divided into the experimental group accepting mesalazine combined with BTV and the control group accepting mesalazine alone. It was found that the overall treatment effective rate was 93.75%, in the experimental group as against 77.50% in the control group, p<0.05. Comparing the levels of inflammatory factors (IL6,IL-8,TNF-a) before and after treatment in the two groups, the improvement degree of the experimental group after treatment was significantly better than that of the control group, p<0.05. The overall nursing satisfaction of the research group was 97.50%, which was significantly higher than the 75.00% of the control group, p<0.05. To conclude that combined therapy of mesalazine and BTV can significantly improve the therapeutic effect in patients with ulcerative colitis, and the scientific nursing mode is an important guarantee to improve the therapeutic results.
Publication Details
Page(s) 1977-1979
Published Journal: Pakistan Journal of Zoology, Volume: 54, Issue: 4, Year: 2022

Request the full text from PASTIC

Keywords
Mesalazine, Ulcerative colitis, Bifid triple viable, High quality nursing, Clinical curative efect
0

Citations

0

Downloads

58

Views